Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
SynerFuse, Inc. currently has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These 2 actions are assigned to 2 distinct examiners, indicating that different individuals are reviewing the company's active applications. This provides a variety of perspectives even within a small portfolio of 2 pending matters.
Both examiners are situated within 1 distinct art unit. While the examiners are different, the administrative and technical oversight is centralized in a single art unit. This suggests that the 2 pending actions involve closely related technologies that fall under the same specialized group at the patent office.
STICE, PAULA J is the busiest examiner for this portfolio with 1 busiest examiner pending action. Since there are 2 pending office actions in total and 2 distinct examiners, the workload is distributed among them. STICE, PAULA J is responsible for one of the 2 actions, representing one part of the current prosecution activity for the company.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STICE, PAULA J | 1 | 81.9% | +21.8% |
| HADDAD, MOUSSA MAHER | 1 | 27.3% | +33.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18128760 | SYSTEMS, DEVICES AND METHODS FOR PLACEMENT OF NEUROMODULATION SYSTEM VIA A SINGLE SURGICAL INCISION AND ANCHORING LEADS | STICE, PAULA J | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17823325 | SYSTEMS, DEVICES AND METHODS FOR DELIVERING A PLURALITY OF ELECTRICAL STIMULATION THERAPIES TO ONE OR MORE ANATOMICAL TARGETS | HADDAD, MOUSSA MAHER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18128760 | SYSTEMS, DEVICES AND METHODS FOR PLACEMENT OF NEUROMODULATION SYSTEM VIA A SINGLE SURGICAL INCISION AND ANCHORING LEADS | STICE, PAULA J | — |
| 17823325 | SYSTEMS, DEVICES AND METHODS FOR DELIVERING A PLURALITY OF ELECTRICAL STIMULATION THERAPIES TO ONE OR MORE ANATOMICAL TARGETS | HADDAD, MOUSSA MAHER | — |
| Art Unit | Apps |
|---|---|
| 3796 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18128760 | SYSTEMS, DEVICES AND METHODS FOR PLACEMENT OF NEUROMODULATION SYSTEM VIA A SINGLE SURGICAL INCISION AND ANCHORING LEADS | STICE, PAULA J | 3796 | §103 | Non-Final OA | — | Pending | Mar 30, 2023 |
| 17823325 | SYSTEMS, DEVICES AND METHODS FOR DELIVERING A PLURALITY OF ELECTRICAL STIMULATION THERAPIES TO ONE OR MORE ANATOMICAL TARGETS | HADDAD, MOUSSA MAHER | 3796 | §103§112 | Non-Final OA | — | Pending | Aug 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial